Inactivated influenza vaccine in an industrial undertaking.
نویسندگان
چکیده
REFERENCES Bull, D. R., and Burnet, F. M. (1943). Med. J. Aust., 1, 389. Burnet, F. M. (1942). Ibid., 1, 673. (1943). Ibid., 1, 385. Chalkina, 0. M. (1938). Arkh. biol. nauk., 52, 126. Isaacs, A., Negroni, G., and Tyrrell, D. A. J. (1957). Lancet, 2, 886. and Roden, A. T. (1956). Ibid., 2, 697. Mawson, J., and Swan, C. (1943). Med. J. Aust., 1, 394. Meiklejohn, G. (1960). J. Amer. med. Ass., 172, 1354. Pereira, M. S. (1958). Lancet, 2, 668. Smorodintsev, A. A. (1960). Amer. J. publ. Hith, 50, 40. DLrobyshevskaya, A. I., Ostrovskaya, S. M., and Shishkina, 0. 1. (1937). Suve:. Vrach. Zhwr., 41, 403. Tushinsky, M. D., Drobyshevskaya, A. 1., Korovin, A. A., and Osetroff, A. 1. (1937). Amer. J. med. Sci., 194, 159. and Zhdanov, V. M. (1957). Prob. Virol., 2, 65. W.H.O. Technical Reports (1959). No. 170. Expert Committee on Respiratory Virus Disease. Van der Veen, J., and Mulder, J. (1950). Studies on the Antigenic Composition of Human Influenza Virus A Strains. Stenfert K roese, Leyden. Vogel, J., and Shelokov, A. (1957). Science, 126, 358. Zhdanov, V. M., and Solov'ev, V. D. (1952). Cited by V. M. Zhdanov in Uchenie o Grippe, 1958, chap. 10, Sect. 89. Znanie, Moscow.
منابع مشابه
The efficacy of inactivated oil-emulsion H9N2 avian influenza vaccine
An experimental inactivated oil-emulsion H9N2 avian influenza vaccine was formulated with 3 parts ofinactivated avian influenza antigen A/Chicken/Iran/101/1998(H9N2) emulsified in 7 parts of oil adjuvant.Twelve week-old specific pathogen-free (SPF) chickens were divided into seven groups of 10 birds. Sixgroups were vaccinated with 1, 1/10th, 1/50th, 1/100th, 1/200th and 1/400th field dose of th...
متن کاملImmunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation
Avian influenza (AI) H9N2 is a low pathogenic virus subtype belonging to Orthomyxoviridae family. Given the prevalence of this subtype as an infectious agent in poultry industry, special attention has been always directed toward the development of vaccine production against this infection. The vaccine of this infection is produced by killing the virus and using a mixture of inactivated antigen ...
متن کاملEvaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken
In the present study, the potency and immunogenicity of the inactivated bivalent vaccine of Newcastle disease (ND) and avian influenza (AI) produced by Razi institute in Iran were compared with a similar imported vaccine administered by standard methods to specific-pathogen-free (SPF) chicken. A total of 150 twenty-one-day-old SPF chickens were used for evaluating Razi and imported inactivated ...
متن کاملSafety of a Trivalent Inactivated Influenza Vaccine in Health Care Workers in Kurdistan Province, Western Iran; A Longitudinal Follow-up Study
We studied the safety of a trivalent inactivated surface antigen (split virion, inactivated) influenza vaccine, Begrivac® (Novartis Company), widely used in health care workers in Kurdistan. A longitudinal follow-up study was performed in Sanandaj city, west of Iran, recruiting 936 people. A questionnaire was completed for each participant, and all symptoms or abnormal physical findings were re...
متن کاملPartial Quality Control of Inactivated Split Human Influenza Vaccine 2008-9
Background and Aims: Influenza vaccination is one of the best way to prevent and control influenza worldwide. It is manufactured by WHO-licensed companies based on the WHO expertise committee annually. The aim of this study was partial quality control of the commercial human influenza vaccine 2008-9 and its matching with the circulating strains. Materials and Methods: The trivalent imported vac...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British medical journal
دوره 1 5284 شماره
صفحات -
تاریخ انتشار 1962